| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 9.433 | 22.546 | 30.329 | 67.927 | 77.602 |
| Total Income - EUR | - | - | - | - | - | 9.433 | 22.546 | 30.329 | 67.927 | 77.602 |
| Total Expenses - EUR | - | - | - | - | - | 644 | 981 | 1.320 | 11.106 | 14.006 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 8.789 | 21.564 | 29.009 | 56.820 | 63.596 |
| Net Profit/Loss - EUR | - | - | - | - | - | 8.522 | 20.969 | 28.250 | 56.141 | 61.315 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Neurologie Dr. Suciu Titus S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 1.837 | 1.748 | 1.751 |
| Current Assets | - | - | - | - | - | 8.691 | 36.836 | 29.315 | 62.392 | 62.328 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 1.245 | 2.044 | 24.059 | 48.805 | 42.020 |
| Cash | - | - | - | - | - | 7.445 | 34.793 | 5.255 | 13.587 | 20.308 |
| Shareholders Funds | - | - | - | - | - | 8.563 | 29.343 | 28.299 | 56.190 | 61.363 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 127 | 7.494 | 2.852 | 7.950 | 2.716 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neurologie Dr. Suciu Titus S.r.l.